Improvement of cardiopulmonary exercise capacity in patients with obstructive sleep apnea syndrome under CPAP therapy;Verbesserung der kardiopulmonalen leistungsfähigkeit bei patienten mit obstruktivem schlafapnoesyndrom unter CPAP-langzeittherapie

Medizinische Klinik

Volumn 101, Issue 2, 2006, Pages 107-113

  Schlosser, Barbara Monika ^a   Walther, Jörg Werner ^a   Rasche, Kurt ^b   Torsten, Bauer Thomas ^a   Orth, Maritta ^a   De Zeeuw, Justus ^a   Schultze Werninghaus, Gerhard ^a   Duchna, Hans Werner ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b Pneumologie Allergologie und Beatmungsmedizin   (Germany)

Author keywords

Cardiopulmonary exercise capacity; Sleep apnea syndrome; Spiroergometry

Indexed keywords

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MALE; OXYGEN CONSUMPTION; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; SPIROMETRY; BLOOD; EXERCISE TEST; LONG TERM CARE; LUNG VENTILATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

OXYGEN;

ADULT; CONTINUOUS POSITIVE AIRWAY PRESSURE; EXERCISE TEST; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; OXYGEN; PULMONARY VENTILATION; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 33646586074     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1015-y     Document Type: Article

References (34)

1. American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea. Sleep 1995;18:511-3.
2. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
3. Breuer HW. Spiroergometrie - Vorschläge zur Standardisierung und Interpretation. Pneumologie 2004;58:553-65.
4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003;289:2560-71.
5. Cloward TV, Walker JM, Farney RJ, et al. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003;124:594-601.
6. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32.
7. Duchna H-W, Grote L, Andreas S, et al., and the Working Group "Kreislauf und Schlaf" of the Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (German Sleep Society, 2003). Sleep-disordered breathing and cardio- and cerebrovascular disease: update 2003 of clinical significance and future perspectives. Somnologie 2003;7:1-21.
8. Duchna H-W, Guilleminault C, Stoohs RA, et al. Vascular reactivity in obstructive sleep apnea syn-drome. Am J Respir Crit Care Med 2000;161:187-91.
9. Gitt AK, Winter UJ, Fritsch J, et al. Vergleich der vier verschiedenen Methoden zur respiratorischen Bestimmung der anaeroben Schwelle bei Normal-personen, Herz- und Lungenkranken. Z Kardiol 1994;83:Suppl 3:37-1-2.
10. Hein H, Raschke F, Köhler D, et al. Leitlinie zur Diagnostik und Therapie der schlafbezogenen Atmungsstörungen. Pneumologie 2001;55:339-42.
11. Imadojemu VA, Gleeson K, Quraishi SA, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive pressure therapy. Am J Respir Crit Care Med 2002;165:950-3.
12. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30-6.
13. Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 2004;27:1053-55.
14. Lavie P. Pro/con editorial. Pro: Sleep apnea causes cardiovascular disease. Am J Respir Crit Care Med 2004;169:147-8.
15. Löllgen H, Dirschedl P, Fahrenkrog U. Belastungsprogramme in der Spiroergometrie. Z Kardiol 1994;83:Supp:43-50.
16. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801.
17. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
18. Pepperell J, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomised parallel trial. Lancet 2002;359:204-10.
19. Rühle K-H. Praxisleitfaden der Spiroergometrie. Stuttgart: Kohlhammer, 2001.
20. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:152-8.
21. Sauleda J, Garcia-Palmer FJ, Tarraga S, et al. Skeletal muscle changes in patients with obstructive sleep apnoea syndrome. Respir Med 2003;97:804-10.
22. Schulz R, Hüsken H, Englisch C, et al. CPAP-Therapie verbessert die kardiopulmonale Leistungsfähigkeit von Patienten mit obstruktiven Schlafapnoe - eine spiroergometrische Untersuchung. Pneumologie 2001;55:S39.
23. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
24. Siegrist J, Peter J, Himmelmann J, et al. Erfahrungen mit einem Anamnesebogen zur Diagnostik der Schlafapnoe. Prax Klin Pneumol 1987;41:357-63.
25. Stradling J. Pro/con editorial. Con: Sleep apnea does not cause cardiovascular disease. Am J Respir Crit Care Med 2004;169:147-8.
26. Taguchi O, Hida W, Okabe S, et al. Improvement of exercise performance with short-term nasal continuous positive airway pressure in patients with obstructive sleep apnea. Tohoku J Exp Med 1997;183:45-53.
27. Treese N, Akbulut Ö, Coutinho M, et al. Halbliegende kardiopulinonale Belastung bei Herzgesunden mittleren Alters. Z Kardiol 1994;83:138-1-5.
28. Ulfberg J, Carter N, Talbäck M, et al. Excessive daytime sleepiness at work and subjective work performance in the general population and among heavy snorers and patients with obstructive sleep apnea. Chest 1996;110:659-63.
29. Wasserman K. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger, 1999.
30. White J, Cates C, Wright J. Continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database Syst Rev 2002;2:CD001106.
31. Wonisch M, Kraxner W, Hödl R, et al. Spiroergometrie in der Kardiologie - klinische Anwendungsmöglichkeiten. J Kardio 2003;10:440-4.
32. Wunder T. Bedeutung der Spiroergometrie in der pneumologischen Praxis unter besonderer Berücksichtigung des Schlaf-Apnoe-Syndroms. Dissertation, Medizinischen Hochschule Hannover, 2002.
33. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
34. Ziegler MG, Mills PJ, Loredo JS, et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001;120:887-93.